Why Researchers Choose Penn Medicine
Penn Hematology/Oncology follows the University of Pennsylvania's long tradition of excellence in patient care and clinical research. Researchers choose Penn Medicine because:
- As part of Penn's Abramson Cancer Center, hematologists/oncologists at Penn Medicine have access to one of the largest clinical trials programs in the country.
- The Abramson Cancer Center is one of only 40 National Cancer Institute-designated comprehensive cancer centers in the country, and has been rated "exceptional" by the National Cancer Institute; the highest peer review designation awarded by the U.S. government's principal agency for cancer research.
- Researchers new to Penn can expect to collaborate and learn from some of the best minds in medicine.
- Penn researchers are successful in winning highly competitive grants.
- Penn offers an interactive, highly networked and supportive working environment.
- Researchers at Penn have the opportunity to solve significant problems in their fields.
- Penn Hematology/Oncology clinicians and researchers participate in groundbreaking studies, and frequently share in the leadership of clinical trials with other nationally renowned cancer centers.
Learn more about Penn Hematology/Oncology's research and clinical trials
